AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12750967 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond 1 + F2000
Number of subjects: 0
Study 12750967 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt L‐Pop + experimental flowable composite
Number of subjects: 0
Study 12750967 — intervention group
Group type: COMPARATOR
Intervention: Control (deionized water)
Number of subjects: 0
Study 12750967 — intervention group
Group type: EXPERIMENTAL
Intervention: Compomer restorations
Number of subjects: 0
Study 10364993 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 20 mg i.v. every 30 s to a maximum of 5 mg kg‐1
Number of subjects: 20
Study 10364993 — intervention group
Group type: COMPARATOR
Intervention: Thiopental 25 mg i.v. every 30 s
Number of subjects: 20
Study 8896392 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF at doses of 0.3 and 1.0 microgram/kg/d
Number of subjects: 0
Study 8896392 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF
Number of subjects: 0
Study 2071885 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (clinically effective doses)
Number of subjects: 53
Study 2071885 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranylcypromine (single treatment)
Number of subjects: 53
Study 2071885 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline and Tranylcypromine (combination treatment)
Number of subjects: 53
Study 2071885 — intervention group
Group type: COMPARATOR
Intervention: Control (none specified)
Number of subjects: 53
Study 6402091 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 45
Study 6402091 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 45
Study 30161086 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.0% Menthol (M)
Number of subjects: 47
Study 30161086 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (P)
Number of subjects: 47
Study 30161086 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 47
Study 30691396 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated varicella-zoster vaccine
Number of subjects: 1500
Study 27353247 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary arm and upper body exercise programme
Number of subjects: 70
Study 25923580 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO mouth‐rinse (6.4% maltodextrin)
Number of subjects: 9
Study 25923580 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 9
Study 24667460 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal glucagon-like peptide-1 (GLP-1) 1.2 mg administered before every meal for 2 weeks
Number of subjects: 26
Study 24667460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 22971530 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates (clodronate therapy group)
Number of subjects: 53
Study 22971530 — intervention group
Group type: COMPARATOR
Intervention: Simple chemotherapy (control group)
Number of subjects: 53
Study 19397644 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable membrane (MC)
Number of subjects: 14
Study 19397644 — intervention group
Group type: COMPARATOR
Intervention: Periosteum (PC)
Number of subjects: 14
Study 18086048 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite (CaHA)
Number of subjects: 117
Study 18086048 — intervention group
Group type: COMPARATOR
Intervention: Human-based collagen
Number of subjects: 117
Study 15057674 — intervention group
Group type: EXPERIMENTAL
Intervention: Humalog Mix50 injected three times daily
Number of subjects: 40
Study 15057674 — intervention group
Group type: COMPARATOR
Intervention: Premixed human insulin 30/70 injected twice daily
Number of subjects: 40
Study 10807752 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin treatment
Number of subjects: 867
Study 10807752 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 867
Study 8623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (1080 mg icosapentaenoic acid, 720 mg docosahexaenoic acid, and 1.5 mg vitamin E) daily for 2 months
Number of subjects: 42
Study 8623866 — intervention group
Group type: COMPARATOR
Intervention: Placebo for the first 2 months
Number of subjects: 42
Study 8623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil for 2 months after placebo
Number of subjects: 42
Study 1535329 — intervention group
Group type: EXPERIMENTAL
Intervention: Didemnin B at 2.6 mg/m2 iv every 28 days
Number of subjects: 43
Study 1535329 — intervention group
Group type: EXPERIMENTAL
Intervention: Didemnin B at 5.6 mg/m2 iv every 28 days
Number of subjects: 43
Study 1535329 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetrexate at 12 mg/m2/day iv for 5 days, repeated every 21 days
Number of subjects: 43
Study 6419679 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lysine hydrochloride therapy (400 mg, three times a day)
Number of subjects: 21
Study 6419679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 30553130 — intervention group
Group type: EXPERIMENTAL
Intervention: Home monitoring with IT-supported specialist management
Number of subjects: 202
Study 30553130 — intervention group
Group type: COMPARATOR
Intervention: Home monitoring alone
Number of subjects: 202
Study 30815169 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute care patient portal
Number of subjects: 63
Study 25968166 — intervention group
Group type: EXPERIMENTAL
Intervention: QS Alex laser
Number of subjects: 17
Study 25968166 — intervention group
Group type: COMPARATOR
Intervention: QS Nd:YAG laser
Number of subjects: 17
Study 22920815 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) in patients with CHF
Number of subjects: 146
Study 22920815 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) in patients with SH
Number of subjects: 146
Study 22920815 — intervention group
Group type: COMPARATOR
Intervention: Continuous glucose monitoring (CGM) in outpatients
Number of subjects: 146
Study 22920815 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) during hypoglycemia
Number of subjects: 146
Study 22920815 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) during euglycemia
Number of subjects: 146
Study 22920815 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) during hyperglycemia
Number of subjects: 146
Study 20868803 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 1156
Study 20868803 — intervention group
Group type: COMPARATOR
Intervention: Off-pump CABG
Number of subjects: 1156
Study 20868803 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1156
Study 18293124 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day instrument
Number of subjects: 134
Study 18293124 — intervention group
Group type: COMPARATOR
Intervention: 7-day instrument
Number of subjects: 134
Study 18293124 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting 100% adherence at more than half of study visits
Number of subjects: 134
Study 16181527 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture plus needling in DU20
Number of subjects: 50
Study 16181527 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture plus needling in HT7
Number of subjects: 50
Study 16181527 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture plus needling in DU26
Number of subjects: 50
Study 16181527 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of DU20, DU26, and HT7
Number of subjects: 50
Study 16181527 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture for hemiplegia
Number of subjects: 50
Study 14625515 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional golfers (PR)
Number of subjects: 128
Study 14625515 — intervention group
Group type: EXPERIMENTAL
Intervention: Collegiate golfers (CO)
Number of subjects: 128
Study 14625515 — intervention group
Group type: EXPERIMENTAL
Intervention: General amateur golfers (AM)
Number of subjects: 128
Study 14625515 — intervention group
Group type: EXPERIMENTAL
Intervention: Collegiate recreational golfers (RE)
Number of subjects: 128
Study 14625515 — intervention group
Group type: COMPARATOR
Intervention: Non-golfing college students (CG)
Number of subjects: 128
Study 14625515 — intervention group
Group type: COMPARATOR
Intervention: Senior population of non-golfers (SC)
Number of subjects: 128
Study 10782483 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis ointment applied four times daily
Number of subjects: 90
Study 10782483 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir ointment applied four times daily
Number of subjects: 90
Study 10782483 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment applied four times daily
Number of subjects: 90
Study 10782483 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis ointment
Number of subjects: 90
Study 8781676 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed, ultrafiltered cow's milk whey formula (Profylac), n = 32
Number of subjects: 91
Study 8781676 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary cow's milk formula, n = 39
Number of subjects: 91
Study 8781676 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed exclusively for more than 9 months, n = 20 (control group)
Number of subjects: 91
Study 1355880 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolemic haemodilution for 2 hours (Group A)
Number of subjects: 75
Study 1355880 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolemic haemodilution for 4 hours (Group B)
Number of subjects: 75
Study 1355880 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolemic haemodilution for 6 hours (Group C)
Number of subjects: 75
Study 4074444 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg AQ‐A 39 intravenously
Number of subjects: 6
Study 4074444 — intervention group
Group type: COMPARATOR
Intervention: Control/Placebo
Number of subjects: 6
Study 31503423 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely randomized tree learning models
Number of subjects: 0
Study 29190155 — intervention group
Group type: EXPERIMENTAL
Intervention: PC-18 at 37.5 mg twice daily
Number of subjects: 0
Study 29190155 — intervention group
Group type: EXPERIMENTAL
Intervention: PC-18 at 7.5 mg twice daily
Number of subjects: 0
Study 29190155 — intervention group
Group type: EXPERIMENTAL
Intervention: PC-18 at 12.5 mg twice daily
Number of subjects: 0
Study 29190155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27475046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone ester-based nutrition
Number of subjects: 39
Study 24462244 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions coded using the motivational interviewing skill code 2.5
Number of subjects: 170
Study 24462244 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions
Number of subjects: 170
Study 22894938 — intervention group
Group type: EXPERIMENTAL
Intervention: Race-relevant Implicit Association Test (IAT)
Number of subjects: 0
Study 22894938 — intervention group
Group type: COMPARATOR
Intervention: Race-irrelevant Implicit Association Test (IAT)
Number of subjects: 0
Study 22894938 — intervention group
Group type: COMPARATOR
Intervention: Explicit prejudice measure
Number of subjects: 0
Study 22894938 — intervention group
Group type: COMPARATOR
Intervention: White interaction partner
Number of subjects: 0
Study 20645521 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelaic acid gel 15% plus doxycycline 40 mg once daily
Number of subjects: 207
Study 20645521 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole gel 1% plus doxycycline 40 mg once daily
Number of subjects: 207
Study 17988756 — intervention group
Group type: EXPERIMENTAL
Intervention: Short messaging service (SMS) and Internet intervention for 12 months
Number of subjects: 51
Study 17988756 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study 19137909 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of famotidine with calcium carbonate and magnesium hydroxide
Number of subjects: 12
Study 19137909 — intervention group
Group type: COMPARATOR
Intervention: Common formulation of famotidine
Number of subjects: 12
Study 15016779 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified urinary FSH (u-hFSH)
Number of subjects: 50
Study 15016779 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human FSH (r-hFSH)
Number of subjects: 50
Study 15016779 — intervention group
Group type: COMPARATOR
Intervention: Control group (normally menstruating women)
Number of subjects: 50
Study 12539560 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 76
Study 12539560 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 76
Study 12539560 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 76
Study 9374884 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition improvement project based on home garden production and nutrition education
Number of subjects: 720
Study 9374884 — intervention group
Group type: COMPARATOR
Intervention: Control commune (Ching Cong)
Number of subjects: 720
Study 8339853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulodexide administration during hyperglycaemia
Number of subjects: 0
Study 8339853 — intervention group
Group type: COMPARATOR
Intervention: Induced hyperglycaemia
Number of subjects: 0
Study 8339853 — intervention group
Group type: COMPARATOR
Intervention: Type 1 diabetic patients (basal state)
Number of subjects: 0
Study 3756378 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-meal condition
Number of subjects: 0
Study 3756378 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise exposure
Number of subjects: 0
Study 3756378 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of trait or state anxiety
Number of subjects: 0
Study 11791960 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrrh at a dose of 10 mg/kg of body weight/day for three days
Number of subjects: 204
Study 11791960 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrrh at a dose of 10 mg/kg of body weight/day for six days (re-treatment)
Number of subjects: 204
Study 11791960 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy specimens six months after treatment
Number of subjects: 204
Study 30975678 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week, group-based, individualised, patient-centred rehabilitation programme consisting of multimodal exercise, exercise education and health education
Number of subjects: 0
Study 30975678 — intervention group
Group type: COMPARATOR
Intervention: Usual care (ie, no care)
Number of subjects: 0
Study 29319209 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroquinolone prophylaxis
Number of subjects: 230
Study 29319209 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad-spectrum antibiotics
Number of subjects: 230
Study 29319209 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction therapy with fluoroquinolone prophylaxis
Number of subjects: 230
Study 29319209 — intervention group
Group type: COMPARATOR
Intervention: Induction therapy without prophylaxis (DFCI 05-001)
Number of subjects: 230
Study 27093482 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid-containing supplements
Number of subjects: 162
Study 27093482 — intervention group
Group type: COMPARATOR
Intervention: Educational text messages (TMs)
Number of subjects: 162
Study 27093482 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplements, no TMs)
Number of subjects: 162
Study 27093482 — intervention group
Group type: COMPARATOR
Intervention: TM only
Number of subjects: 162
Study 27093482 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement only
Number of subjects: 162
Study 27093482 — intervention group
Group type: EXPERIMENTAL
Intervention: TM + supplement
Number of subjects: 162
Study 24165197 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 Hz stimulation
Number of subjects: 20
Study 24165197 — intervention group
Group type: COMPARATOR
Intervention: 130 Hz stimulation
Number of subjects: 20
Study 23033992 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 8
Study 23033992 — intervention group
Group type: COMPARATOR
Intervention: Filtered air (FA) exposure
Number of subjects: 8
Study 20961243 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral transcatheter implantation of a balloon-expandable bovine pericardial valve (TAVI)
Number of subjects: 358
Study 20961243 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (including balloon aortic valvuloplasty)
Number of subjects: 358
Study 18341722 — intervention group
Group type: EXPERIMENTAL
Intervention: Herniography
Number of subjects: 310
Study 16111538 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of HOXA9 expression in haemopoietic cells in adults over sixty.
Number of subjects: 0
Study 16111538 — intervention group
Group type: COMPARATOR
Intervention: Low levels of HOXA9 expression in haemopoietic cells during early adulthood.
Number of subjects: 0
Study 11881904 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to produce a spatial consequence in the environment to a spatially neutral stimulus
Number of subjects: 0
Study 11881904 — intervention group
Group type: COMPARATOR
Intervention: Control experiments
Number of subjects: 0
Study 10404003 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioners
Number of subjects: 232
Study 10404003 — intervention group
Group type: COMPARATOR
Intervention: Medical officers
Number of subjects: 232
Study 7538514 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release hydromorphone (CR)
Number of subjects: 18
Study 7538514 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release hydromorphone (IR)
Number of subjects: 18
Study 1689988 — intervention group
Group type: EXPERIMENTAL
Intervention: KRN 8601 (rhG-CSF) at a dose of 75 micrograms/body administered subcutaneously for 14 days after the second cycle of chemotherapy
Number of subjects: 0
Study 1689988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 456734 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimebutine (Mebutin), 200 mg three times daily for 4 weeks
Number of subjects: 20
Study 456734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 456734 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimebutine (Mebutin)
Number of subjects: 20
Study 30714205 — intervention group
Group type: EXPERIMENTAL
Intervention: Wi‐Fi users (n=174)
Number of subjects: 312
Study 30714205 — intervention group
Group type: COMPARATOR
Intervention: Wi‐Fi nonusers (n=138)
Number of subjects: 312
Study 28858567 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1455
Study 28858567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tel-Ed (web-based OSA education)
Number of subjects: 1455
Study 28858567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tel-TM (CPAP telemonitoring with automated feedback)
Number of subjects: 1455
Study 28858567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tel-both (Tel-Ed and Tel-TM)
Number of subjects: 1455
Study 28858567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tel-Ed
Number of subjects: 1455
Study 28858567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tel-TM
Number of subjects: 1455
Study 28858567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tel-both
Number of subjects: 1455
Study 27547895 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of a review lecture, electronic information card, and monthly individual physician feedback via email.
Number of subjects: 66
Study 27547895 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention).
Number of subjects: 66
Study 27547895 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention.
Number of subjects: 66
Study 24012064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette packages with 'natural' descriptors
Number of subjects: 7647
Study 24012064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette packages with filter references
Number of subjects: 7647
Study 24012064 — intervention group
Group type: COMPARATOR
Intervention: Contraband cigarettes
Number of subjects: 7647
Study 22507979 — intervention group
Group type: EXPERIMENTAL
Intervention: Mipomersen 200 mg weekly subcutaneous injection
Number of subjects: 33
Study 22507979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 22507979 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver fat content assessment
Number of subjects: 33
Study 22507979 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver needle biopsy
Number of subjects: 33
Study 20518185 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoints compatibility rules
Number of subjects: 0
Study 20518185 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoints compatibility rules based on experimental researches
Number of subjects: 0
Study 18030236 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-protected (LP) TPN
Number of subjects: 0
Study 18030236 — intervention group
Group type: COMPARATOR
Intervention: Light-exposed (LE) TPN
Number of subjects: 0
Study 16054553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nut diet (30 g/d nuts)
Number of subjects: 28
Study 16054553 — intervention group
Group type: COMPARATOR
Intervention: Cereal diet (Canola oil enriched cereal)
Number of subjects: 28
Study 12670859 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 86
Study 12670859 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 86
Study 12670859 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 86
Study 11192563 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary vocational rehabilitation programme with additional work training and case management
Number of subjects: 24
Study 11192563 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation programme
Number of subjects: 24
Study 8991314 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists classified as more effective based on patient outcomes in active treatment.
Number of subjects: 0
Study 8991314 — intervention group
Group type: COMPARATOR
Intervention: Moderately and less effective therapists.
Number of subjects: 0